Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market 2020 Research Forecast 2026

Published On: Dec 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 78022

Gastroesophageal reflux disease (GERD), also known as acid reflux, is a long-term condition where stomach contents come back up into the esophagus resulting in either symptoms or complications.
Patent expiry of blockbuster drugs prescribed for the treatment of acid reflux disorders is majorly attributable for the downfall of this market.
In 2020, the global Gastroesophageal Reflux Disease (GERD) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2026, with a CAGR of xx% during 2020-2026.

This report focuses on the global Gastroesophageal Reflux Disease (GERD) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gastroesophageal Reflux Disease (GERD) Therapeutics development in United States, Europe and China.

The key players covered in this study
AstraZeneca
Eisai
GSK
Takeda
Johnson & Johnson
...

Market segment by Type, the product can be split into
Antacids
Pro-kinetic agents
H2 Receptor Blockers
Proton Pump Inhibitors (PPIs)

Market segment by Application, split into
Heartburn
Acid reflux disorders

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gastroesophageal Reflux Disease (GERD) Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Gastroesophageal Reflux Disease (GERD) Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gastroesophageal Reflux Disease (GERD) Therapeutics are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type (2015-2026)
1.4.2 Antacids
1.4.3 Pro-kinetic agents
1.4.4 H2 Receptor Blockers
1.4.5 Proton Pump Inhibitors (PPIs)
1.5 Market by Application
1.5.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2015-2026)
1.5.2 Heartburn
1.5.3 Acid reflux disorders
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size
2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Growth Trends by Regions
2.2.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions (2015-2026)
2.2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Regions (2015-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Manufacturers
3.1.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Manufacturers (2015-2020)
3.1.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Manufacturers (2015-2020)
3.1.3 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players Head office and Area Served
3.3 Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Product/Solution/Service
3.4 Date of Enter into Gastroesophageal Reflux Disease (GERD) Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2015-2020)
4.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2015-2020)

5 United States
5.1 United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
5.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in United States
5.3 United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
5.4 United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application

6 Europe
6.1 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
6.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Europe
6.3 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
6.4 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application

7 China
7.1 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
7.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in China
7.3 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
7.4 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application

8 Japan
8.1 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
8.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Japan
8.3 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
8.4 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
9.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
9.4 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application

10 India
10.1 India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
10.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in India
10.3 India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
10.4 India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2015-2020)
11.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Central & South America
11.3 Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
11.4 Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application

12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
12.1.4 AstraZeneca Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020)
12.1.5 AstraZeneca Recent Development
12.2 Eisai
12.2.1 Eisai Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
12.2.4 Eisai Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020)
12.2.5 Eisai Recent Development
12.3 GSK
12.3.1 GSK Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
12.3.4 GSK Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020)
12.3.5 GSK Recent Development
12.4 Takeda
12.4.1 Takeda Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
12.4.4 Takeda Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020)
12.4.5 Takeda Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
12.5.4 Johnson & Johnson Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2015-2020)
12.5.5 Johnson & Johnson Recent Development

13 Market Forecast 2020-2026
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2020-2026)
13.10 Market Size Forecast by Application (2020-2026)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details